Pacira BioSciences PCRX
NASDAQ PCRX
$36.48 +0.02 (+0.05%)
As of: Nov 12, 2026 · 9:42 AM EST

Pacira BioSciences (PCRX) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Pacira BioSciences' Return on Capital Employed [ROCE] was 1.80% in Q2 2026, up 10.15 percentage points from -8.35% a year earlier but down 0.34 percentage points from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Pacira BioSciences came in at 1.49%, up 7.34 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of -4.31 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -5.85% in FY2024 (-11.58 pp), 5.73% in FY2023 (+2.26 pp), 3.47% in FY2022 (-4.33 pp) and 7.79% in FY2021 (+2.00 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -8.35% (Q2 2025) and 9.37% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for four straight quarters, with an average year-over-year change of -1.68 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2026 (a gain of 10.15 percentage points); the worst was Q2 2025 (a drop of 14.42 percentage points).
  • Per Business Quant data, PCRX's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was 2.14% (Q1 2026), 1.65% (Q4 2025) and 3.17% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Pacira BioSciences 1.46 Bn 468.61 Mn 139.42 Mn 3.26%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.26%
Jun 30, 2026 1.80%
Mar 31, 2026 2.14%
Dec 31, 2025 1.65%
Sep 30, 2025 3.17%
Jun 30, 2025 -8.35%
Mar 31, 2025 -6.74%
Dec 31, 2024 -5.98%
Sep 30, 2024 -5.08%
Jun 30, 2024 6.07%
Mar 31, 2024 7.00%
Dec 31, 2023 6.02%
Sep 30, 2023 3.09%
Jun 30, 2023 3.38%
Mar 31, 2023 2.63%
Dec 31, 2022 3.85%
Sep 30, 2022 4.63%
Jun 30, 2022 5.02%
Mar 31, 2022 5.24%
Dec 31, 2021 7.53%
API Access

Pacira BioSciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PCRX&period=max&api_key=YOUR_API_KEY